Goldman Sachs Starts Moonlake Immunotherapeutics (MLTX ) at Neutral, 'Competing Against Large Pharma Companies Is No Easy Task'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Goldman Sachs Starts Moonlake Immunotherapeutics (MLTX ) at Neutral, 'Competing Against Large Pharma Companies Is No Easy Task'
(NASDAQ: MLTX) Delayed: 16.47 -0.03 (0.18%)
Previous Close $16.50    52 Week High $ 
Open $16.31    52 Week Low $ 
Day High $16.67    P/E N/A 
Day Low $16.30    EPS $ 
Volume 980,789